Possibility of polyunsaturated fatty acids for the prevention and treatment of neuropsychiatric illnesses

Journal of Pharmacological Sciences

Volumn 124, Issue 3, 2014, Pages 294-300

  Hashimoto, Michio ^a   Maekawa, Motoko ^b   Katakura, Masanori ^a   Hamazaki, Kei ^c,d,e   Matsuoka, Yutaka ^d,e,f  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION DISASTER MEDICAL CENTER   (Japan)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; n 3 polyunsaturated fatty acid; Neuropsychiatric illness

Indexed keywords

OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID;

BRAIN DEVELOPMENT; DEMENTIA; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; LIPID COMPOSITION; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY MECHANISM; REVIEW;

CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; DEMENTIA; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; MENTAL DISORDERS; MOOD DISORDERS; NEURAL STEM CELLS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84897383091     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.13R14CP     Document Type: Review

References (36)

1. Umhau JC, Zhou W, Carson RE, Rapoport SI, Polozova A, Demar J, et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res. 2009;50:1259-1268.
2. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, et al. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry. 1996;53:25-31.
3. St Clair D, Xu M, Wang P, Yu Y, Fang Y, Zhang F, et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA. 2005;294:557-562. (Pubitemid 41126897)
4. Brown AS, Susser ES. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophrenia Bulletin. 2008;34:1054-1063.
5. Watanabe A, Toyota T, Owada Y, Hayashi T, Iwayama Y, Matsumata M, et al. Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol. 2007;5:e297.
6. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7:489-503. (Pubitemid 351767117)
7. Cahill LE, Chiuve SE, Mekary RA, Jensen MK, Flint AJ, Hu FB, et al. Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals. Circulation. 2013;128:337-343.
8. Hashimoto M, Hossain S. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. J Pharmacol Sci. 2011;116:150-162.
9. Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience. 2006;139:991-997.
10. Maekawa M, Takashima N, Matsumata M, Ikegami S, Kontani M, Hara Y, et al. Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS One. 2009;4:e5085.
11. DeCarolis NA, Eisch AJ. Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacology. 2010;58:884-893.
12. Katakura M, Hashimoto M, Okui T, Shahdat HM, Matsuzaki K, Shido O. Omega-3 polyunsaturated fatty acids enhance neuronal differentiation in cultured rat neural stem cells. Stem Cells Int. 2013;2013:490476.
13. Lin PY, Chiu CC, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J Clin Psychiatry. 2012;73:1245-1254.
14. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63:1402-1408. (Pubitemid 44547551)
15. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, et al. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1538-1544.
16. Hashimoto M, Yamashita K, Kato S, Tamai Y, Tanabe Y, Mitarai M, et al. Beneficial effects of daily dietary Omega-3 polyunsaturated fatty acid supplementation on age-related cognitive decline in elderly japanese with very mild dementia. J Aging Res Clin Practice. 2012;1:193-201.
17. Uauy R, Dangour AD. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev. 2006;64:S24-S33; discussion S72-S91.
18. Cole GM, Ma QL, Frautschy SA. Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids. 2009;81: 213-2121.
19. Hossain S, Hashimoto M, Katakura M, Miwa K, Shimada T, Shido O. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Ab1-42 fibrillation and Ab1-42-induced toxicity in SH-SY5Y cells. J Neurochemistry. 2009;111:568-579.
20. Hashimoto M, Hossain S, Agdul H, Shido O. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. Biochimica et Biophysica Acta. 2005;1738:91-98.
21. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged alzheimer mouse model. J Neuroscience. 2005;25:3032-3040. (Pubitemid 40463537)
22. Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, et al. Modeling Alzheimer's disease with ipscs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell. 2013;12:487-496.
23. Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351:1213.
24. Lin P-Y, Huang S-Y, Su K-P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010;68:140-147.
25. Lin PY, Mischoulon D, Freeman MP, Matsuoka Y, Hibbeln J, Belmaker RH, et al. Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry. 2012;17:1161-1163.
26. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry. 2012;73:81-86.
27. Hamazaki K, Hamazaki T, Inadera H. Polyunsaturated fatty acids and their related enzymes in postmortem brain tissues of patients with psychiatric disorders. Current Psychopharmacol. 2013;2:66-72.
28. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008; 9:46-56. (Pubitemid 350295688)
29. Bhattacharya A, Sun D, Rahman M, Fernandes G. Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice. J Nutr Biochem. 2007;18:23-30. (Pubitemid 44827716)
30. Mozaffari-Khosravi H, Yassini-Ardakani M, Karamati M, Shariati-Bafghi SE. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, doubleblind, placebo-controlled trial. Eur Neuropsychopharmacol. 2013;23:636-644.
31. Kitamura T, Saitoh Y, Takashima N, Murayama A, Niibori Y, Ageta H, et al. Adult neurogenesis modulates the hippocampus-dependent period of associative fear memory. Cell. 2009;139: 814-827.
32. He C, Qu X, Cui L, Wang J, Kang JX. Improved spatial learning performance of fat-1 mice is associated with enhanced neuro genesis and neuritogenesis by docosahexaenoic acid. PNAS. 2009;106:11370-11375.
33. Matsuoka Y. Clearance of fear memory from the hippocampus through neurogenesis by Omega-3 fatty acids: a novel preventive strategy for posttraumatic stress disorder? Biopsychosoc Med. 2011;5:3.
34. Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Hashimoto K, Hamazaki T. Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open- label pilot study. J Clin Psychopharmacol. 2010 30:217-219.
35. Nishi D, Koido Y, Nakaya N, Sone T, Noguchi H, Hamazaki K, et al. Fish oil for attenuating posttraumatic stress symptoms among rescue workers after the great east japan earthquake: a randomized controlled trial. Psychother Psychosom. 2012;81: 315-317.
36. Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Hamazaki T, Hashimoto K. Potential role of brain-derived neurotrophic factor in Omega-3 fatty acid supplementation to prevent posttraumatic distress after accidental injury: an open-label pilot study. Psychother Psychosom. 2011;80:310-312.